Table:
begin	end	state
1	53	cytoplasmic
54	75	transmembrane
76	114	non-cytoplasmic
115	139	transmembrane
140	171	cytoplasmic
172	199	transmembrane
200	210	non-cytoplasmic
211	232	transmembrane
233	239	cytoplasmic
240	260	transmembrane
261	279	non-cytoplasmic
280	298	transmembrane
299	322	cytoplasmic
323	345	transmembrane
346	372	non-cytoplasmic
373	397	transmembrane
398	418	cytoplasmic
419	439	transmembrane
440	445	non-cytoplasmic
446	470	transmembrane
471	476	cytoplasmic
477	493	transmembrane
494	499	non-cytoplasmic
500	520	transmembrane
521	542	cytoplasmic

Input:
>PP_4946
MGFVGKCTGRCNLQKKNGCTFFALLHSIRRLGATTNGVVAHDKNKRQGTRMGNPLTITFV
IYIAAMVLIGFAAYRATNNLSDYILGGRSLGSVVTALSAGASDMSGWLLMGLPGAIYFAG
LSEAWIAIGLTVGAYLNWLFVAGRLRVQTEHNGDALTLPDYFSSRFEDNSGLLRIISAIV
ILVFFTIYCASGIVAGARLFESTFGMSYETALWAGAAATIAYTFVGGFLAVSWTDTVQAS
LMIFALILTPVIVLISTGGFDQTFAAIEAVNPANFDMLKGATFIGIISLMGWGLGYFGQP
HILARFMAADSVKSIAKARRISMTWMILCLAGTCAVGFFGIAYFSAHPELAGPVSENHER
VFIELAKILFNPWVAGVLLSAILAAVMSTLSCQLLVCSSALTEDFYKAFLRKNASQVELV
WVGRLMVLAVALIAIAMAANPENRVLGLVAYAWAGFGAAFGPVVLISVLWKGMTRNGALA
GIVVGALTVILWKNFDTLGLYEIIPGFLFASIAIVLVSKLGSPSQTMVKRFEAADAAYHA
DK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server